Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial

PURPOSE: Oral adsorbents delay disease progression and improve uremic symptoms in patients with chronic kidney disease (CKD). DW-7202 is a newly developed oral adsorbent with high adsorptive selectivity for uremic toxins. We evaluated patient preference for and adherence to DW-7202 versus AST-120 th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kee, Youn Kyung, Han, Sang Youb, Kang, Duk-Hee, Noh, Jung Woo, Jeong, Kyung Hwan, Kim, Gheun-Ho, Kim, Yang Wook, Kim, Beom Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820454/
https://www.ncbi.nlm.nih.gov/pubmed/33381933
http://dx.doi.org/10.3349/ymj.2021.62.1.41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820454/
https://www.ncbi.nlm.nih.gov/pubmed/33381933
http://dx.doi.org/10.3349/ymj.2021.62.1.41

Ejemplares similares